First Time Loading...

Immuno-Biological Laboratories Co Ltd
TSE:4570

Watchlist Manager
Immuno-Biological Laboratories Co Ltd Logo
Immuno-Biological Laboratories Co Ltd
TSE:4570
Watchlist
Price: 503 JPY 1.21% Market Closed
Updated: May 18, 2024

EV/EBIT
Enterprise Value to EBIT

85.2
Current
-18.1
Median
22.1
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
85.2
=
Enterprise Value
4.3B
/
EBIT
50.2m
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A

See Also

Discover More